BackVBI Vaccines Overview

VBI Vaccines Other Current Liabilities

Track VBI Vaccines's other current liabilities ($6.4M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Current Liabilities
$6.36M
64.85% YoYΔ $-11.74M vs prior year quarter

Peer trimmed avg / median

Loading

VBI Vaccines Other Current Liabilities History

Loading

VBI Vaccines vs. peers: Other Current Liabilities Comparison

Loading

VBI Vaccines Other Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

VBI Vaccines (VBIV) FAQ

As of the most recent data (March 2024), VBIV shows a other current liabilities of $6.4M. That compares with $18M in the prior-year period — down 64.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, VBIV's other current liabilities is now $6.4M (was $18M) — a 64.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether VBI Vaccines is outperforming or lagging.

Tracking VBIV's other current liabilities over time shows whether VBI Vaccines is scaling, shrinking, or reshaping that part of the business. The current reading is $6.4M That compares with $18M in the prior-year period — down 64.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current liabilities page, Stockcircle has VBI Vaccines's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current liabilities (currently $6.4M) with ownership activity and broader fundamentals.

VBI Vaccines's other current liabilities is $6.4M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.